ESSA Pharma Inc. (EPIX)

ESSA Pharma Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	86.31	103.71	33.7	57.08	137.83	56.32
Short-Term Investments	27.56	23.05	114.37	110.16	57.1	22.01
Cash & Short-Term Investments	113.87	126.76	148.08	167.24	194.93	78.33
Cash Growth	-16.20%	-14.39%	-11.46%	-14.21%	148.85%	46.90%
Other Receivables	0.42	0.16	0.14	0.01	0.49	0.31
Receivables	0.42	0.16	0.14	0.01	0.49	0.31
Prepaid Expenses	0.88	0.3	0.21	1.79	1.99	1.48
Other Current Assets	-	0.33	0.38	0.02	0.19	0.18
Total Current Assets	115.17	127.56	148.8	169.06	197.6	80.3
Property, Plant & Equipment	0.25	0.3	0.07	0.19	0.31	-
Other Long-Term Assets	-	0.26	0.26	0.26	0.26	0.28
Total Assets	115.42	128.11	149.12	169.51	198.17	80.57
Accounts Payable	1.59	2.4	2.03	0.95	1.43	0.68
Accrued Expenses	-	0.77	1.39	1.22	2.38	0.47
Current Portion of Leases	0.13	0.12	0.08	0.13	0.12	0.06
Total Current Liabilities	1.71	3.3	3.5	2.31	3.93	1.2
Long-Term Leases	0.15	0.21	-	0.08	0.21	-
Other Long-Term Liabilities	-	-	-	-	0.02	0.13
Total Liabilities	1.87	3.51	3.5	2.39	4.16	1.33
Common Stock	279.86	279.86	278.16	278.09	277.42	131.09
Additional Paid-In Capital	58.68	54.81	49.05	44.04	36.44	31.2
Retained Earnings	-222.91	-208	-179.46	-152.88	-117.78	-80.97
Comprehensive Income & Other	-2.09	-2.06	-2.12	-2.14	-2.08	-2.08
Total Common Equity	113.55	124.61	145.63	167.12	194.01	79.24
Shareholders' Equity	113.55	124.61	145.63	167.12	194.01	79.24
Total Liabilities & Equity	115.42	128.11	149.12	169.51	198.17	80.57
Total Debt	0.28	0.33	0.08	0.21	0.33	0.06
Net Cash (Debt)	113.59	126.43	148	167.03	194.6	78.27
Net Cash Growth	-16.19%	-14.57%	-11.39%	-14.17%	148.61%	57.77%
Net Cash Per Share	2.56	2.86	3.36	3.79	5.06	3.49
Filing Date Shares Outstanding	44.39	44.39	44.14	44.07	43.98	33.6
Total Common Shares Outstanding	44.39	44.39	44.1	44.07	43.98	32.06
Working Capital	113.45	124.26	145.3	166.75	193.67	79.09
Book Value Per Share	2.56	2.81	3.30	3.79	4.41	2.47
Tangible Book Value	113.55	124.61	145.63	167.12	194.01	79.24
Tangible Book Value Per Share	2.56	2.81	3.30	3.79	4.41	2.47

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q